Status:

RECRUITING

Brain Areas of Time-To-Contact Perception: an Awake Surgery Study

Lead Sponsor:

University Hospital, Toulouse

Conditions:

Brain Tumors

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

During a brain surgery targeted to remove a brain tumor, the neurosurgeon wakes up the patient to delimit the tumor area exactly, and identify the surrounding areas, to limit the surgery damages. The ...

Detailed Description

Time to contact (TTC) estimation is a major visual function that allows an observer determining the time a moving object will take to reach him. It is however striking to note that the different brain...

Eligibility Criteria

Inclusion

  • For the patients:
  • Brain tumor that does not affect the dominant hand motricity. The patient that have a tumor in an area targeted for a cortical stimulation will be automatically enrolled within the Pre-End group.
  • Who will agree with all terms and sign the experimental agreement
  • Correct or corrected vision, as allowed by the surgery constraints
  • With no known oculomotor abnormalities (list of exclusion in Annexe)
  • Affiliated to a social security system
  • For the control group:
  • Who will agree with all terms and sign the experimental agreement
  • Correct or corrected vision
  • With no known oculomotor abnormalities.
  • Affiliated to a social security system

Exclusion

  • For the patients:
  • Brain tumor located in the occipital area
  • Legally protected patient, or with unknown ability to sign the experimental agreement, as determined by the medical team.
  • Medical background of neurological diseases of the central nervous system, as Parkinson, Alzheimer, stroke
  • Pregnancy
  • For the control group:
  • Legally protected patient, or with unknown ability to sign the experimental agreement, as determined by the medical team.
  • Medical background of neurological diseases of the central nervous system, as Parkinson, Alzheimer, stroke
  • Pregnancy

Key Trial Info

Start Date :

September 16 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

240 Patients enrolled

Trial Details

Trial ID

NCT04128306

Start Date

September 16 2019

End Date

December 1 2025

Last Update

October 30 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital

Toulouse, France, 31000